Navigation Links
Wrigley's Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Association's Seal of Acceptance
Date:9/25/2007

Wrigley products first and only chewing gums in the U.S. to earn trusted

symbol of safety and effectiveness

CHICAGO, Sept. 25 /PRNewswire-FirstCall/ -- The Wm. Wrigley Jr. Company (NYSE: WWY) today announced its Orbit(R), Extra(R) and Eclipse(R) sugar-free chewing gums have earned the universally trusted American Dental Association (ADA) Seal of Acceptance. Orbit, Extra and Eclipse are the first and only gums in the U.S. to earn this recognition because they are clinically proven to help fight cavities, strengthen teeth and reduce harmful plaque acids. The ADA Seal makes clear that chewing Wrigley's Orbit, Extra and Eclipse sugar-free gums can help maintain good oral health.

"We're proud to lead the industry by being awarded this important recognition," said Bill Wrigley, Jr., Executive Chairman and Chairman of the Board. "Wrigley has been championing the oral health benefits of chewing gum for nearly 20 years. Now the ADA Seal of Acceptance makes perfectly clear to dental professionals and consumers that chewing Wrigley's Orbit, Extra and Eclipse sugar-free gums is a convenient and portable way to help maintain and improve oral health."

The ADA's Seal of Acceptance has been a respected symbol of safety and effectiveness for more than 75 years. The organization awarded its Seal of Acceptance to Wrigley after a thorough analysis of nearly 20 years' worth of independent scientific research which demonstrated chewing Wrigley sugar-free gums helped to protect dental health. Both clinical and laboratory studies underwent rigorous review by the ADA's Council on Scientific Affairs, with assistance by staff scientists and some of its more than 100 expert consultants.

"We congratula
'/>"/>

SOURCE The Wm. Wrigley Jr. Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Sugar-Free Yogurt Can Stop Bad Breath
2. Tobacco chewing leads to dental caries
3. Chewing gum found to increase brainpower
4. An unlikely contender for speedy surgery recovery: Chewing gum
5. Bihar Banned Tobacco Chewing In State Assembly
6. Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth
7. Obesity Passed Onto Children By Ancestors Smoking And Chewing Betel Nuts
8. A Chewing Gum That Helps in Fighting Tooth Decay
9. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
10. Scientists Awarded Appropriately For Contribution Towards Medical Research
11. Abstain from sex- the latest mantra of American teens

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-USNewswire/--WhenmostpeopleheartheacronymTM...ivepatientsthehelptheyneed.TMJstandsfortheTemporal...acts/connectswithyourskull(temporalbone). ,, Th...painwithchewing,clickingorpoppingofthejaw.Butmanyo...:headaches,fatigue,sleepdisturbances,irritability,...
(Date:11/25/2009)...5/PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc...sttwoinvestoreventsinDecember: ,, ASHBriefing... ,, Principalinvestigatorswilldiscussdatapresen...ctorymultiplemyeloma,asfeaturedatthe51stAmericanSo...NewOrleans,LA.Theteleconferencewillbeginat9:00a.m....
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009).../PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,...esearch,titled"ADifficultBalance-PainManagement,Dr...TheNewEnglandJournalofMedicine. ,, (Logo: http:...,, Inthearticle,WoodcockdiscussesFDAeffortstost...honeeditandmanagingtherisksposedbyvariousanalgesic...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...ore research is being published showing the benefi...l tolerated by most patients due to the aftertaste...hers at Banner now say they have developed a chewa...oft chewable shell that can be taken without water...
... medications available , one must also be wary of ...ng to the Drug Control Department, 63 batches of s...killers and cardiac medicines, are being sold in B... drug racket first came to light in May-end this y...
...n B9 has been known to help in the brain developme...e to this reason it is administered to pregnant wo...ngen University, Netherlands has proposed that thi... increased levels of homocysteine. This amino acid...
... Lancet investigated the efficacy of acupuncture c...puncture in patients with osteoarthritis of the kn...reat many types of patients with chronic pain. ...o the acupuncture group, second group with 76 pati...
...able to stop the geriatric population from falling...ntain their balance. The device is called Yak...e that conforms to the footwear and helps the peop...of the number of falls they have on wearing the de...
...rom peripheral arterial disease may lose their lim...s to attend to them. Research findings report that...r surgeons, report less number of cases where pati...ften the only symptom experienced is a recurring p...
Other Medicine News:
(Date:11/25/2009)...ire-FirstCall/--Formanyofthemillionsofhearingimpai...ated hearingloss ,theholidaysmaynotbeallthathappy,...cepresidentofHearUSA(Amex: EAR ),oneofAmerica,slar...eshavelinkedhearinglosstostress,frustration,andsoc...gatheringswithfamiliesandfriends,whenmanyofthosewi...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...DevicesMarketAnalysisandForecaststo2015 ,, ht...ental-Devices-Market-Analysis-and-Forecasts-to-201...sisandForecaststo2015 ,, Summary ,, Thisre...tarelatingtotheUSdentaldevicesmarket.Italsooffersd...
(Date:11/25/2009)...all/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicec...ptivesurgicaltreatmentsforthespine,announcedtodayt...09,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfo...pany,sproductsandwillincludecommentsfrommanagement...nnumbersare1-877-407-4018fordomesticcallersand1-20...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 1Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 2Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 4eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 1eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 2
...groups show dose-dependent PSA d... call to be held today at 8:30 A.M. Eastern time -...: MDVN ) today announced that its selective andro...ed serum levels of prostate specific,antigen (PSA)...rolled in,the first two dose groups of its ongoing...
...ustained virologic response in non-respond...results in line with previous studies of long-acti...th less frequent dosing -, - Final data from Phas..., Annual Meeting of the American Association for t... (AASLD) -, ROCKVILLE, Ma., Nov. 5 Human G...
Other Medicine Technology:Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 2Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 3Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
Hi-Top Post Op Shoe
EZY Close
Forefoot Reliever
Ultra 90 Fixed Plantar Fasciitis Splint
Medicine Products: